MDxHealth SA (MDXH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...

By Yahoo! Finance | Nov 7, 2024 at 02:38 AM EST

Michael McGarrity, CEO, discusses a balanced strategy of internal and acquisition-driven development. Revenue growth is fueled by urology and pathology adoption, with focus on tissue-based tests. Market access efforts aim to optimize payer mix distribution. Early uptake of germline test shows promise for future revenue.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.